Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ampio Pharmaceuticals Inc (NYSE MKT LLC:AMPE)

2.95
Delayed Data
As of Aug 28
 +0.09 / +3.15%
Today’s Change
1.94
Today|||52-Week Range
9.01
-13.99%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$153.4M

Company Description

Ampio Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development of therapies to treat prevalent inflammatory conditions. Its product pipeline includes new uses for approved drugs and new molecular entities for important therapeutic areas, including metabolic disease, eye disease, kidney disease, inflammation, sexual dysfunction and CNS disease. The company was founded by Michael Macaluso in March 2008 and is headquartered in Greenwood Village, CO.

Contact Information

Ampio Pharmaceuticals, Inc.
373 Inverness Parkway
Englewood Colorado 80112
P:(720) 437-6500
Investor Relations:

Employees

Shareholders

Mutual fund holders4.63%
Other institutional22.12%
Individual stakeholders10.82%

Top Executives

Michael MacalusoChairman & Chief Executive Officer
Gregory A. GouldChief Financial Officer, Secretary & Treasurer
David Bar-OrDirector & Chief Scientific Officer
Vaughan Lennox CliftChief Regulatory Affairs Officer